No complication has been reported except occasional and transient burning sensation
IL2-STAT5 Immune Signatures Predict Responses to PD-1 Inhibition and Azacitidine Treatment in Acute Myeloid Leukemia (AML): A subset analysis of a Phase 2 Study
In the first 30 days of starting a GLP-1 medication, most patients begin to notice subtle but meaningful changes in appetite, energy levels, and digestion
No food burns fat directly
Images were acquired in a charge-coupled device camera (Eagle), and gold particles quantified in at least five cells per experiment using Image J
Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP